We are live on ! Find out more
ATNM icon

Actinium Pharmaceuticals
ATNM

41 hedge funds and large institutions have $23.1M invested in Actinium Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more call options, than puts

Call options by funds: $1.35M | Put options by funds: $498K

20% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 10

16.82% more ownership

Funds ownership: 0.73% → 17.56% (+17%)

24% less capital invested

Capital invested by funds: $30.5M → $23.1M (-$7.41M)

31% less funds holding

Funds holding: 59 → 41 (-18)

62% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 29

Holders
41
Holders Change
-18
Holders Change %
-30.51%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
12
Reduced
10
Closed
29
Calls
$1.35M
Puts
$498K
Net Calls
+$854K
Net Calls Change
+$849K

Top Buyers

Rank Fund Capital Flow
1
JGC
J. Goldman & Co
New York
+$1.07M
2
BCM
Bridgeway Capital Management
Texas
+$637K
3
RCMNY
Rubric Capital Management (New York)
New York
+$634K
4
Deutsche Bank
Deutsche Bank
Germany
+$525K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$469K

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$4.85M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.27M
3
BlackRock
BlackRock
New York
-$1.13M
4
CH
CVI Holdings
Delaware
-$1M
5
SCM
Sio Capital Management
New York
-$910K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
51
California Public Employees Retirement System
California
– -$14K -1,333 Closed
IB
52
Intrust Bank
Kansas
– -$14K -1,333 Closed
FA
53
FCG Advisors
New Jersey
– -$13K -1,257 Closed
TSS
54
Two Sigma Securities
New York
– -$13K -1,242 Closed
LWM
55
Laidlaw Wealth Management
New York
– -$10K -933 Closed
DY
56
Dowling & Yahnke
California
– -$8K -762 Closed
OC
57
Oppenheimer & Co
New York
– -$5K -467 Closed
SFWA
58
Summit Financial Wealth Advisors
Louisiana
– -$5K -467 Closed
Ameriprise
59
Ameriprise
Minnesota
– -$5K -436 Closed
PAG
60
Private Advisor Group
New Jersey
– -$4K -333 Closed
WSFS
61
Wilmington Savings Fund Society
Delaware
– -$4K -333 Closed
TC
62
Truvestments Capital
Florida
– -$2K -211 Closed
CAN
63
Cetera Advisor Networks
California
– -$2K -167 Closed
VNA
64
Valley National Advisers
Pennsylvania
– -$1K -67 Closed
Simplex Trading
65
Simplex Trading
Illinois
– -$33 -3 Closed
Bank of America
66
Bank of America
North Carolina
– +$198 +18 +56%
1 2
3

ATNM Hedge Fund Activity: Q3 2020 in Review

41 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q3 2020, worth a combined $23.1M — down 24% from $30.5M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of ATNM and 11 opened new positions — a net loss of 18 holders — while 10 trimmed existing stakes and 12 added.

The largest buyer was J. Goldman & Co, adding an estimated $1.07M. The largest seller was Consonance Capital Management, cutting an estimated $4.85M.

  • 41 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q3 2020, down from 59 in Q2 2020.
  • Funds reported $23.1M of Actinium Pharmaceuticals stock for Q3 2020, down 24% quarter-over-quarter.
  • 11 funds opened new Actinium Pharmaceuticals positions in Q3 2020 and 29 closed out, a net change of -18 holders.
  • The largest Actinium Pharmaceuticals buyer in Q3 2020 was J. Goldman & Co, an estimated $1.07M added.
  • The largest Actinium Pharmaceuticals seller in Q3 2020 was Consonance Capital Management, an estimated $4.85M sold.

Based on aggregated 13F filings for Q3 2020.